The U.S. now has three ways to immunize vulnerable infants and seniors for RSV, a leading cause of hospitalization in young children.
of more than 7,000 women around the world found Pfizer’s vaccine administered in the third trimester of pregnancy to be effective in preventing severe illness requiring medical attention. It was 82 percent effective at protecting infants from severe illness during the three months after birth, and waned to 69 percent effective over six months. The study found no major safety concerns.
It’s unclear whether the maternal RSV vaccine, Abrysvo, would be available in time to protect infants born during the upcoming RSV season, which usually starts in fall and peaks in winter. The vaccine needs to be recommended by the Centers for Disease Control and Prevention before the shots are administered. The committee that advises the CDC on vaccine recommendations is expected to meet again in mid-September and could potentially consider the RSV vaccine then.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA approves 1st maternal RSV vaccine to help protect infantsThe U.S. Food and Drug Administration has approved the first maternal vaccine intended to help protect newborns against respiratory syncytial virus (RSV).
Read more »
US FDA approves Pfizer's maternal RSV vaccine to protect infantsThe U.S. Food and Drug Administration on Monday approved Pfizer's respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to protect their babies.
Read more »
FDA approves first RSV vaccine for pregnancy to protect newbornsExpectant parents could soon have another new option this fall to protect their newborns from RSV, the most common cause of hospitalization in American infants.
Read more »
FDA approves Pfizer maternal RSV vaccine for infantsPfizer hopes that its respiratory syncytial virus vaccine will be available to the public by the end of October or the beginning of November.
Read more »
Pfizer maternal RSV vaccine gets FDA approvalNew shot designed to protect babies against leading cause of hospitalization is expected to be available this fall.
Read more »